Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D98EUL
|
|||
| Drug Name |
GSK4182136
|
|||
| Synonyms |
Xevudy; sotrovimab; VIR-7831
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Approved in EU | [1] | |
| Company |
GlaxoSmithKline
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | COVID-19 spike glycoprotein (S) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of GlaxoSmithKline | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.